S&E bio Co., Ltd., a biotechnology company specializing in exosomal microRNA-based therapies, has received approval from Korea's Ministry of Food and Drug Safety (MFDS) to initiate a Phase 1b clinical ...

By Shreya Dasgupta Massive wildfires that killed at least 32 people and scorched an area nearly double the size of Seoul in ...

ToBrite has developed advanced Vision-AI technology capable of accurately detecting passengers getting on and off the bus. It ...

New findings suggest 'BluePDRN' offers a sustainable, scalable alternative to traditional animal-derived PDRNs SEOUL, South Korea, April 28, 2025 /PRNewswire/ -- Amorepacific revealed research ...

World's First Android-Based Concurrent Multi-User Framework Redefines In-Vehicle Experience with Single OS Solution SEOUL, ...

As spring brings sunlight and warmth to South Korea, more people can be spotted around the city, taking walks, going on runs ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...

Faith leaders and human rights groups condemned a Vatican university s decision to host an Azerbaijani state-sponsored ...